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Introduction
The regulation of energy metabolism is one of the
major points of homeostatic system, in which the brain
acts as the central coordinator. The important role try-
ing to synchronize response to fluctuations in energy
balance play brain-gut axis, realized by autonomic
nervous system and endocrine system. Many of
peripheral factors (leptin, insulin, peptide YY, ghrelin)
are involved in regulation of energy balance [1-3].
Ghrelin is a of 28 amino acids hormone that has
been recently isolated from rat and human stomach
[4]. This peptide is recognized as a main endogenous
ligand for growth hormone secretagogue receptors
(GHS-R) and it play important roles in growth hor-
mone release and control of feeding behaviour [4,5].
The acyl group at serine-3 of ghrelin molecule is
essential for binding and activing GHS-R. GHS-R1a is
highly expressed in the hypothalamus and pituitary
gland, consistent with the actions of ghrelin on the
anterior pituitary, as well as with its influence in the
control of appetite, food intake and energy balance
[4,6]. Moreover, GHS-R1a expression has also been
reported in other areas of the central nervous system,
that affect biological rhythms, mood, cognition mem-
ory and learning, such as the hippocampus, substantia
nigra, ventral tegmental area, dorsal and medial raphe
nuclei, Edinger-Westphal nucleus and pyriform cortex
[7,8]. In addition, multiple peripheral organs, such as
the stomach, intestine, pancreas, thyroid, gonads, adre-
nal, kidney, heart and vascular system as well as sev-
eral endocrine tumors and cell lines have been found to
express GHS-R1a [8,9].
The stomach is the main source of circulating ghre-
lin level and this fact has been demonstrated by their
decrease after gastrectomy [10]. Ghrelin expression
has been detected in X/A-like cells that account for 20-
25% of all endocrine cells in the mucosa [4,6,11].
Ghrelin has been also localized in many other tissues
such as: pancreas, bowel, kidney, placenta, gonads,
thyroid, adrenal, lung, pituitary, hypothalamus [4,8,12]
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and in many neoplastic tissues such as gastric, intes-
tinal carcinoid, thyroid and breast carcinomas [9,13].
The potential physiological role of ghrelin as an
autocrine and paracrine factor in those tissues is still
investigated. The endocrine function of ghrelin seems
to be better known [1,2]. 
Ghrelin is able to induce adipogenesis in rodents by
stimulating appetite and food intake as well as by mod-
ulating energy balance with reduced fat utilization
[8,14,15]. The orexigenic action of ghrelin and GHS is
independent from GH-releasing activity and is mediat-
ed by a specific central network of neurones that is
also modulated by leptin [15]. Ghrelin and leptin
might be complementary players of one regulatory
system that has developed to inform the central nerv-
ous system about the status of energy balance
[7,15,16]. From the gastrointestinal tract, ghrelin could
regulate food intake and energy homeostasis reaching
GHS-R in the hypothalamus through the general circu-
lation [7,14]. Moreover, ghrelin expression has also
been demonstrated in a previously uncharacterized
group of neurones adjacent to the third ventricle
between the dorsal, ventral, paraventricular and arcu-
ate hypothalamic nuclei [2,3,14]. Within the hypothal-
amus, ghrelin binds mostly on presynaptic terminals of
neuropeptide Y (NPY) neurones; it stimulates the
activity of arcuate NPY neurones and mimicks the
effect of NPY in the paraventricular nucleus of the
hypothalamus [3,14,17,18]. There is also evidence that
acetylcholine mediates the ghrelin impact on appetite
and energy balance [19]. 
The aim of this study was was the evaluation of
gastric ghrelin immunoreactivity and ghrelin plasma
concentration in male Wistar rats with hyperthy-
roidism.
Material and methods
Animals. The study was performed on twenty, male Wistar rats
weighting approximately 90-100 g at the beginning of the experi-
ment. All animals had free access to standard granulated diet and
drinking water. The animals were housed in plastic cages at 22°C
and constant humidity, with a 12/12-light/dark cycle, beginning at
7 am. The rats were randomly divided into 2 groups with 10 ani-
mals in each group: rats with hyperthyroidism and control rats
treated with vehicle under the same experimental conditions.
Experimental model of hyperthyroidism was induced by intraperi-
toneal injection of L-thyroxine (Sigma Chemical Co) at the dose of
80 μg/kg daily over 21 days.
At the end of experiment, the animals were anaesthetized with
pentobarbital sodium (50 mg/kg b.wt), their abdomen was opened
by midline incision and the blood was taken from the abdominal
aorta of each rat for measurement of TSH and ghrelin serum con-
centration by radioimmunoassay (RIA). Subsequently, all rats
underwent resection of distal part of stomach. The tissues were
fixed in Bouin's fluid and were prepared to immunohistochemical
investigation. 
Determination of TSH and ghrelin plasma concentration. The
blood, taken from abdominal aorta of each rat, was collected into
polypropylene tubes without anticoagulant and was incubated in
room temperature until the clot was formed and then centrifuged
(2500 × g for 15 min). The supernatant (serum) was removed and
stored at -20°C until a final analysis. Ghrelin and TSH level was
determined by the double-antibody radioimmunoassay technique.
The protocol for radioimmunoassay kit is accessible on the web
site: www.phoenixpeptide.com. 
The immunohistochemical study. The distal part of stomach of
each animal was fixed in Bouin's fluid for one day at 4°C. After
thorough washing in 0.1 M phosphate buffer (pH=7.4) at 4°C, the
tissue was routinely embedded in paraffin, and 5-μm-thick sections
were cut. For blocking of the endogenous peroxidase activity
Peroxidase Blocking Reagent (Dako Poland) was used over 10
minutes. In these studies a specific antibody against ghrelin
(Phoenix) was used. After washing with distilled water and 0.05 M
TRIS-HCl pH=7.4, three times for 5 minutes, the sections were
incubated with the antibody for 1 hour at room temperature and
then, sections were washed three times in TRIS buffer. Subse-
quently, the EnVision method was applied, according to the proto-
col for identification of the immunocytochemical reaction [20].
The sections were counterstained with Mayer's haematoxylin. In
the negative control, the specific antibody was omitted in the stain-
ing procedure. Positive control was done for specific tissue recom-
mended by the producer. The histological preparations were sub-
jected to analysis, using Olympus B ×50 microscope.
Image analysis. To quantify immunoreactivity of the examined
marker, computerized image analysis was performed. Images were
captured via video link to an Olympus BX50 microscope at 20
objective magnification, so the tissue fully occupied each field, and
was scanned by the computer. Pictures were adjusted for optimal
contrast, fixed at the same brightness levels, and saved in a buffer-
ing system. Staining was analyzed using Olympus Cell D image
analysis computer system as described in details by Postek et al.
[21]. The average optical density was analyzed for cells expressing
ghrelin in both, experimental and control rats. The average optical
density is the method measured values range from 0 to 255 where
0 means black and 255 white color.
Ethical issues. All procedures were performed in compliance with
the European Communities Council Directive of 24 November
1986 (86/609/EEC) and were approved by the Local Ethics Com-
mittee in Bia³ystok.
Statistics. All values were given as mean ± SD. The Mann-Whit-
ney test was used for testing the differences between both groups
in the intensity of immunocytochemical reactions. The Student-t
test was used for the evaluation of the differences between groups
in ghrelin plasma concentrations. The value p<0.05 was considered
to be significant.
Results
Radioimmunoassay
After 21 days of L-thyroxine treatment plasma TSH
concentration was significantly (p<0.001) reduced
(mean 0.52 ± 0.14 µIU/ml) as compared to the respec-
tive value in the control rats (2.89 ± 0.59 µIU/ml) (Fig.
1). Initial food intake did not differ between two
groups. After 1 week of treatment the food intake grad-
ually increased compared to the control group. At the
end of experiments body weights significantly
decreased in rats with hyperthyroidism. The adminis-
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tration of L-thyroxin over 21 days caused significantly
decreased of plasma ghrelin concentration (mean
388.8 ± 58.3 pg/ml) in comparison to the control rats
(mean 634.8 ± 62.2 pg/ml) (Fig. 2). 
Results of histological study
Ghrelin immunoreactive (Ghr-IR) cells were distrib-
uted predominantly as single cells, locally in varying
number in the deep zone of the gastric mucosa. Ghr-IR
cells were most abundant in lower parts of gastric
proper glands, while in the neck zone of the glands
they were observed sporadically, both in the control
(Fig. 4) and in the experimental groups of rats (Fig. 6).
These cells were usually round or oval, sometimes
spindle-shaped, seldom irregular with short processes.
Their nuclei were usually large, round structures that
occupy the central portions of cells. While in the X/A
like cells of control rats GH-immunoreactivity
appeared as a strong reaction (Fig. 4 and 5), after
chronic treatment with L-thiyroxine (Fig. 6 and 7),
GH-immunoreactivity in gastric mucosa was stronger.
The average optical density of immunocytochemical
reaction for ghrelin, evaluated by Olympus Soft pro-
gram, was significantly decreased in L-thyroxine
injected groups of rats in comparison to the control
gastric mucosa (Fig. 3). 
Discussion
The mechanism of L-thyroxin action down-regulated
ghrelin secretion is still unknown. In animals, ghrelin
is secreted in a pulsatile manner without strict correla-
tion with GH levels but in association with food intake
episodes [16,22]. In humans, ghrelin secretion under-
goes marked variations throughout the day, with peaks
preceding food intake, suggesting that the latter is trig-
gered by ghrelin discharge [2,23]. Circulating ghrelin
levels are negatively associated with body mass index;
ghrelin secretion is increased in anorexia and cachex-
ia, reduced in obesity and normalized by recovery of
ideal body weight [1]. The only exception to the nega-
tive association between body mass index and ghrelin
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Fig. 1. The effect of L-thyroxine on plasma TSH concentration.
Values are means ± SD obtained from 10 rats. *p<0.001 vs control
(Student's test).
Fig. 2. The effect of L-thyroxine on plasma ghrelin concentration.
Values are means ± SD obtained from 10 rats. *p<0.001 vs control
(Student's test).
Fig. 3. Average optical density of immunohistochemical staining
for ghrelin in X/A-like cells after administration of L-thyroxine.
Values are means ± SD, *p<0,001 vs control (Mann-Whitney test).
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Fig. 4. Light micrograph of gastric mucosa of a control rat. Positive immunohisochemical reaction for ghrelin is observed in X/A-like
cells (magnification ×170). Fig. 5. Light micrograph of gastric mucosa of a control rat. Positive immunohisochemical reaction for ghre-
lin is observed in X/A-like cells (magnification ×340). Fig. 6. Light micrograph of gastric mucosa of rat treated with L-thyroxine over 21
days. The strong immunohistochemical reaction for ghrelin is observed in most of X/A-like cells (magnification ×170).  Fig. 7. Light
micrograph of gastric mucosa of rat treated with L-thyroxine over 21 days. The strong immunohistochemical reaction for ghrelin is
observed in most of X/A-like cells (magnification ×340).
secretion is the Prader-Willi syndrome where obesity
is surprisingly associated with ghrelin hypersecretion
[24]. In our study we observed reduction of body
weight and ghrelin plasma concentration after admin-
istration of L-thyroxine in comparison to the control
group. 
Ghrelin changes in response to variations in the
nutritional state are opposite to those of leptin and it
has been suggested that both hormones may act as sig-
nals of the metabolic balance to the central nervous
system [2,7]. In our study, after L-thyroxin administra-
tion the reduction of body weight and hyperphagia
accompanied by a significant decreased of ghrelin
plasma levels were observed. The increase of gastric
mucosal ghrelin -immunoreactivity indicated that L-
thyroxin probably inhibited ghrelin secretion.
It is well known that thyroid hormone stimulates
food intake in humans and rodents [25]. Hyperthyroid
patients have increased appetite and energy consump-
tion [26]. It was found that T3 treated rats had a
marked increase hypothalamic NPY and application of
BIB03304 – antagonist of Y1 receptor reduced hyper-
phagia in thyrotoxicosis [25]. Probably another factors
induced hyperphagia in hyperthyroidism for example
through the decreased plasma leptin levels, which
might inhibit gastric ghrelin release [25]. 
The next way trying to explain the inhibition role of
L-thyroxine on ghrelin secretion is hyperinsulinemia
accompanied by hyperthyroidism [27]. Saad et al. [28]
in 2002 reported that hyperinsulinemia reduced plas-
ma ghrelin concentration. Ghrelin secretion is
decreased by either intravenous or oral glucose load as
well as during euglycaemic-hyperinsulinaemic clamp
and even after insulin-induced hypoglycaemia [29,30].
The inhibitory influence of overexposure to insulin on
ghrelin secretion is consistent with the strong negative
association between ghrelin and insulin levels that had
been predicted by the negative correlation between
ghrelin levels and body mass index [23], however, it is
still unclear whether insulin and glucose per se play a
direct inhibitory role in ghrelin secretion [31].
Administration of thyroid hormone stimulate
numerous of metabolic pathways and thermogenesis
[27]. In humans, circulating ghrelin levels are increase
by energy restriction and decrease by food intake indi-
cating that ghrelin secretion is mostly regulated by
metabolic signals [32]. Gastric ghrelin mRNA expres-
sion in rats has been increased by a high-fat diet [33],
although the oral, intravenous or intragastric adminis-
tration of fat has also been shown to decrease circulat-
ing ghrelin levels [34]. Similarly, oral protein adminis-
tration has been reported to increase plasma ghrelin
levels by some authors [32,35] or to decrease them
according to others [34]. In humans, constant lipid
infusion has been reported not to influence plasma
ghrelin levels [30], whereas oral fat administration has
been reported to decrease, although to a lesser extent
than after glucose ingestion [36,37] or even to increase
circulating ghrelin levels [38]. On the other hand, pro-
tein intake has been reported both to increase [36,38]
and not to affect [32,39] circulating ghrelin levels.
Ghrelin secretion has been also inhibited by the acti-
vation of somatostatin receptors. The administration of
pharmacological doses of somatostatin, its natural ana-
logue cortistatin and a synthetic analogue such as
octreotide markedly reduce circulating ghrelin levels
in humans to an extent even higher than that observed
after glucose or insulin administration [40,41]. Ghre-
lin, in turn, increases circulating somatostatin levels
[42], suggesting the existence of a feedback link
between these two peptides. The role of somatostatin
on ghrelin secretion in hyperthyroid state is unknown.
Ghrelin secretion is also under cholinergic control
[19]. The levels of ghrelin are increased and decreased
by muscarinic receptors agonists and antagonists,
respectively [19]. These findings agree with evidence
that the elevation in ghrelin levels induced by food
deprivation is prevented by subdiaphragmatic vagoto-
my and considerably reduced by atropine in rats [43].
Thyrotoxicosis is characterized by profound sympa-
thovagal imbalance, caused by increased sympathetic
activity in the presence of diminished vagal tone[44].
Thyroid hormones increase the density of β-adrenergic
receptors and cAMP accumulation and decrease the
density of α-adrenergic receptors. Attenuated vagal
tone observed during hyperthyroidism may explain
decreased of plasma ghrelin level and increased of gas-
tric mucosa immunoreactivity [19,43].
Conclusions
In conclusion, our study indicated that chronic admin-
istration of L-thyroxine caused the reduction of body
weight and stimulated appetite accompanied by a sig-
nificant decreased of ghrelin plasma levels. The
increase gastric mucosal ghrelin -immunoreactivity
indicated that L-thyroxine probably inhibited ghrelin
secretion. This observation showed that ghrelin is not
responsible for hyperphagia in rats treated with L-thy-
roxine.
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